Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses

Pinghui Feng, Ashlee Moses, Klaus Frueh

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

γ-Herpesviral immune evasion mechanisms are optimized to support the acute, lytic and the longterm, latent phase of infection. During acute infection, specific immune modulatory proteins limit, but also exploit, the antiviral activities of cell intrinsic innate immune responses as well as those of innate and adaptive immune cells. During latent infection, a restricted gene expression program limits immune targeting and cis-acting mechanisms to reduce the antigen presentation as well as antigenicity of latency-associated proteins. Here, we will review recent progress in our understanding of γ-herpesviral immune evasion strategies.

Original languageEnglish (US)
Pages (from-to)285-295
Number of pages11
JournalCurrent Opinion in Virology
Volume3
Issue number3
DOIs
StatePublished - Jun 2013

Fingerprint

Herpesviridae
Adaptive Immunity
Innate Immunity
Immune Evasion
Infection
Antigen Presentation
Antiviral Agents
Proteins
Gene Expression

ASJC Scopus subject areas

  • Virology

Cite this

Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses. / Feng, Pinghui; Moses, Ashlee; Frueh, Klaus.

In: Current Opinion in Virology, Vol. 3, No. 3, 06.2013, p. 285-295.

Research output: Contribution to journalArticle

@article{362c45c30f0a43d987507e0d69a8d635,
title = "Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses",
abstract = "γ-Herpesviral immune evasion mechanisms are optimized to support the acute, lytic and the longterm, latent phase of infection. During acute infection, specific immune modulatory proteins limit, but also exploit, the antiviral activities of cell intrinsic innate immune responses as well as those of innate and adaptive immune cells. During latent infection, a restricted gene expression program limits immune targeting and cis-acting mechanisms to reduce the antigen presentation as well as antigenicity of latency-associated proteins. Here, we will review recent progress in our understanding of γ-herpesviral immune evasion strategies.",
author = "Pinghui Feng and Ashlee Moses and Klaus Frueh",
year = "2013",
month = "6",
doi = "10.1016/j.coviro.2013.05.011",
language = "English (US)",
volume = "3",
pages = "285--295",
journal = "Current Opinion in Virology",
issn = "1879-6257",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses

AU - Feng, Pinghui

AU - Moses, Ashlee

AU - Frueh, Klaus

PY - 2013/6

Y1 - 2013/6

N2 - γ-Herpesviral immune evasion mechanisms are optimized to support the acute, lytic and the longterm, latent phase of infection. During acute infection, specific immune modulatory proteins limit, but also exploit, the antiviral activities of cell intrinsic innate immune responses as well as those of innate and adaptive immune cells. During latent infection, a restricted gene expression program limits immune targeting and cis-acting mechanisms to reduce the antigen presentation as well as antigenicity of latency-associated proteins. Here, we will review recent progress in our understanding of γ-herpesviral immune evasion strategies.

AB - γ-Herpesviral immune evasion mechanisms are optimized to support the acute, lytic and the longterm, latent phase of infection. During acute infection, specific immune modulatory proteins limit, but also exploit, the antiviral activities of cell intrinsic innate immune responses as well as those of innate and adaptive immune cells. During latent infection, a restricted gene expression program limits immune targeting and cis-acting mechanisms to reduce the antigen presentation as well as antigenicity of latency-associated proteins. Here, we will review recent progress in our understanding of γ-herpesviral immune evasion strategies.

UR - http://www.scopus.com/inward/record.url?scp=84880288803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880288803&partnerID=8YFLogxK

U2 - 10.1016/j.coviro.2013.05.011

DO - 10.1016/j.coviro.2013.05.011

M3 - Article

VL - 3

SP - 285

EP - 295

JO - Current Opinion in Virology

JF - Current Opinion in Virology

SN - 1879-6257

IS - 3

ER -